Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia

K Al‐Shali, J Wang, F Rosen, RA Hegele - Clinical genetics, 2003 - Wiley Online Library
K Al‐Shali, J Wang, F Rosen, RA Hegele
Clinical genetics, 2003Wiley Online Library
Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder that is characterized by
defective assembly and secretion of plasma apolipoprotein (apo) B‐containing lipoproteins.
This disorder results from mutations in the MTP gene encoding the microsomal triglyceride
transfer protein. We report a 58‐year‐old male homozygote for a missense mutation, S590I,
in MTP. The patient had a lifelong history of fat malabsorption, but was only diagnosed with
ABL at age 52, based upon such classic features as absence of apo B‐containing …
Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder that is characterized by defective assembly and secretion of plasma apolipoprotein (apo) B‐containing lipoproteins. This disorder results from mutations in the MTP gene encoding the microsomal triglyceride transfer protein. We report a 58‐year‐old male homozygote for a missense mutation, S590I, in MTP. The patient had a lifelong history of fat malabsorption, but was only diagnosed with ABL at age 52, based upon such classic features as absence of apo B‐containing lipoproteins, acanthocytosis, atypical retinitis pigmentosa and markedly depressed serum beta‐carotene concentration. However, his presentation was notable not only by survival to the sixth decade of life without specific treatment, but also by the absence of neurological involvement and by normal serum vitamin E concentration. He subsequently developed adenocarcinoma of the ileum, which required ileal resection. Therefore, this missense mutation appears to be associated with a late‐presenting and relatively mild ABL phenotype that lacks some classical features, particularly neuropathy, but appears to be associated with other atypical features, specifically small intestinal cancer.
Wiley Online Library